← FDA DRUG APPROVALS

FDA ANDA · ANDA085880

BUTALAN

Sponsor: LANNETT

APPLICATION
ANDA085880
TYPE
ANDA
ORIGINAL APPROVAL
1978-08-30
LATEST ACTION
2019-02-06
ROUTE
ORAL
DOSAGE FORM
ELIXIR
MARKETING STATUS
Discontinued

Products

BUTALANDiscontinued
BUTABARBITAL SODIUM 33.3MG/5ML · ELIXIR · ORAL

Approval history

2019-02-06Labeling · Supplement 1 · standardAP
1978-08-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →